These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22762724)

  • 41. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
    Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
    J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The anti-aging, metabolism potential of SIRT1.
    Ghosh HS
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1095-102. PubMed ID: 18821472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing insulin resistance through SIRT1.
    Zabolotny JM; Kim YB
    Cell Metab; 2007 Oct; 6(4):247-9. PubMed ID: 17908551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?
    Timmers S; Hesselink MK; Schrauwen P
    Ann N Y Acad Sci; 2013 Jul; 1290():83-9. PubMed ID: 23855469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Emerging Role of Sirtuin 1 in Cellular Metabolism, Diabetes Mellitus, Diabetic Kidney Disease and Hypertension.
    Guclu A; Erdur FM; Turkmen K
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):131-9. PubMed ID: 26588494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SIRT1 and Autophagy: Implications in Endocrine Disorders.
    Kim JY; Mondaca-Ruff D; Singh S; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():930919. PubMed ID: 35909524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential.
    Kitada M; Koya D
    Diabetes Metab J; 2013 Oct; 37(5):315-25. PubMed ID: 24199159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sirtuins and Insulin Resistance.
    Zhou S; Tang X; Chen HZ
    Front Endocrinol (Lausanne); 2018; 9():748. PubMed ID: 30574122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sirtuin biology and relevance to diabetes treatment.
    Dong XC
    Diabetes Manag (Lond); 2012 May; 2(3):243-257. PubMed ID: 23024708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interplay of Vitamin D and SIRT1 in Tissue-Specific Metabolism-Potential Roles in Prevention and Treatment of Non-Communicable Diseases Including Cancer.
    Nemeth Z; Patonai A; Simon-Szabó L; Takács I
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural Sirtuin1 Activators and Atherosclerosis: an Overview.
    Łanoszka K; Vlčková N
    Curr Atheroscler Rep; 2023 Dec; 25(12):979-994. PubMed ID: 38038821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sirtuin-1 regulation of mammalian metabolism.
    Gillum MP; Erion DM; Shulman GI
    Trends Mol Med; 2011 Jan; 17(1):8-13. PubMed ID: 20971038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rs12778366 single nucleotide polymorphism of Sirtuin 1 (SIRT1) and response to resveratrol supplementation in patients with type 2 diabetes mellitus.
    Gambino R; Fanni G; Togliatto G; Ponzo V; Goitre I; Cassader M; Brizzi MF; Bo S
    Acta Diabetol; 2019 Aug; 56(8):963-966. PubMed ID: 30980188
    [No Abstract]   [Full Text] [Related]  

  • 54. Role of SIRT1 in Chemoresistant Leukemia.
    Fajardo-Orduña GR; Ledesma-Martínez E; Aguiñiga-Sanchez I; Weiss-Steider B; Santiago-Osorio E
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of sirtuin proteins in obesity.
    Metoyer CF; Pruitt K
    Pathophysiology; 2008 Aug; 15(2):103-8. PubMed ID: 18599274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sirt1 Activity in the Brain: Simultaneous Effects on Energy Homeostasis and Reproduction.
    D'Angelo S; Mele E; Di Filippo F; Viggiano A; Meccariello R
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33573212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational evaluation of bioactive compounds in
    Prasetyawan S; Safitri A; Atho'illah MF; Rahayu S
    BioTechnologia (Pozn); 2023; 104(2):171-182. PubMed ID: 37427032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SIRT1 metabolic actions: Integrating recent advances from mouse models.
    Boutant M; Cantó C
    Mol Metab; 2014 Feb; 3(1):5-18. PubMed ID: 24567900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SIRT1 activators: the evidence STACks up.
    Kugel S; Mostoslavsky R
    Aging (Albany NY); 2013 Mar; 5(3):142-3. PubMed ID: 23474671
    [No Abstract]   [Full Text] [Related]  

  • 60. Novel SIRT1 mutation linked to autoimmune diabetes in humans.
    Hughes JW; Herold KC
    Cell Metab; 2013 Mar; 17(3):311-2. PubMed ID: 23473025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.